Published in Thromb Haemost on October 18, 1993
A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest (1997) 0.98
Implications of Gender Difference in Coronary Calcification as Assessed by CT Coronary Angiography. Clin Med Insights Cardiol (2015) 0.85
Plasma Concentration of Endogenous Tissue Plasminogen Activator and the Occurrence of Future Cardiovascular Events. J Thromb Thrombolysis (1994) 0.78
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart (1998) 0.75
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension (2001) 11.18
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (1992) 5.56
Low molecular weight heparin in prevention of perioperative thrombosis. BMJ (1992) 3.36
Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension (1997) 3.21
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation (1996) 3.00
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. Eur Heart J (2002) 2.30
Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension (1998) 2.20
Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin. Thromb Haemost (1999) 2.18
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation (1999) 1.90
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J (1997) 1.76
Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension (1989) 1.72
Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension (1999) 1.71
Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke (2000) 1.62
Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol (2000) 1.59
Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology (1996) 1.58
Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol (2000) 1.57
Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke (1996) 1.55
Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998. Medtronic ICD System Investigators. Pacing Clin Electrophysiol (2000) 1.52
Benefits of progestin contraception in non-allergic angioedema. Clin Exp Allergy (2013) 1.49
Correlation between time-domain measures of heart rate variability and scatterplots in postinfarction patients. Pacing Clin Electrophysiol (1996) 1.43
Relationship between alcohol intake, health and social status and cardiovascular risk factors in the Urban Paris-Ile-de-France Cohort: is the cardioprotective action of alcohol a myth? Eur J Clin Nutr (2010) 1.43
Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet (2008) 1.41
Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol (2010) 1.38
Prevention of venous thromboembolism after orthopedic surgery: the EXPRESS study. J Thromb Haemost (2004) 1.37
The thrombophilic state in cancer patients. Acta Haematol (2001) 1.27
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol (1997) 1.21
[Could treatments with beta-blockers be associated with a reduction in cancer risk?]. Rev Epidemiol Sante Publique (2004) 1.19
Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest (1998) 1.18
Vascular risk factors and morphometric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatry (2009) 1.16
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation (1996) 1.16
Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke (1996) 1.15
Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke (1999) 1.14
Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation (1996) 1.14
Is the relationship between blood pressure and cardiovascular risk dependent on body mass index? Am J Epidemiol (1985) 1.13
The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg. J Clin Pharmacol (1988) 1.13
Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol (1993) 1.11
Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol (2005) 1.11
[Prevalence and course of Wolf-Parkinson-White syndrome in a population of 138,048 subjects]. Ann Med Interne (Paris) (1985) 1.09
Insulin resistance, obesity and breast cancer risk. Maturitas (2008) 1.08
Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet (1999) 1.07
Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol (2005) 1.06
Relationship between biological activity and concentration of a low-molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Haemostasis (1986) 1.06
The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study. J Thromb Haemost (2011) 1.05
Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol (1990) 1.03
Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res (1985) 1.03
Associations between heart rate and other risk factors in a large French population. J Hypertens (1999) 1.02
In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban. J Thromb Haemost (2007) 1.02
A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol (2000) 1.02
Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb (1991) 1.02
Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women. J Am Coll Cardiol (2001) 1.02
New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol (2001) 1.01
[A new heart stimulator: the orthorhythmic pacemaker]. Presse Med (1971) 1.00
Effects of pregnancy on the inter-individual variations in blood levels of lead, cadmium and mercury. Biol Res Pregnancy Perinatol (1986) 1.00
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol (1999) 1.00
Breastfeeding and risk of breast cancer: a metaanalysis of published studies. Hum Reprod Update (2000) 1.00
The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol (1993) 0.98
Prognostic value of plasma renin activity in renovascular hypertension. Circulation (1967) 0.98
A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol (1994) 0.98
The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet (2011) 0.98
Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension (2001) 0.98
The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening. J Med Genet (2009) 0.96
Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost (1999) 0.96
Soluble thrombomodulin as predictor of incident coronary heart disease. Lancet (1999) 0.96
Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod (1995) 0.95
Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol (1996) 0.94
Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. Eur J Endocrinol (2011) 0.93
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb (1993) 0.93
Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol (1986) 0.92
A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance. J Thromb Haemost (2005) 0.92
Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation. Eur J Hum Genet (2008) 0.92
[Venous thrombosis and cancer]. Ann Biol Clin (Paris) (2001) 0.92
Induction of apoptosis using sphingolipids activates a chloride current in Xenopus laevis oocytes. Am J Physiol Cell Physiol (2000) 0.92
European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol (1995) 0.90
Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage. Haemostasis (1993) 0.90
Arteriographically documented coronary artery disease and alcohol consumption in French men. The CORALI Study. Eur Heart J (1993) 0.89
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux. Thromb Haemost (2011) 0.88
Prenatal exposure to lead and cadmium and psychomotor development of the child at 6 years. Neurobehav Toxicol Teratol (1986) 0.88
Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age. J Hypertens (2001) 0.88
Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial. Eur J Cancer Prev (2005) 0.88
Biventricular pacing in severe heart failure patients reverses electromechanical dyssynchronization from apex to base. Pacing Clin Electrophysiol (2000) 0.88
Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion. Am J Med Genet A (2009) 0.88
Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth (2002) 0.87
The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement. J Bone Joint Surg Br (2000) 0.87
Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet (1997) 0.87
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Thromb Haemost (1995) 0.86
Systemic oxidative stress and cognitive performance in the population-based EVA study. Etude du Vieillissement Artériel. Free Radic Biol Med (1998) 0.86
Low compliance with colonoscopic screening in first-degree relatives of patients with large adenomas. Aliment Pharmacol Ther (2006) 0.86
Determinants of left ventricular mass in a French male population. Blood Press (1999) 0.86
Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation. Haemostasis (1986) 0.86
Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Pharmacoepidemiol Drug Saf (2001) 0.86
[Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate]. J Mal Vasc (2011) 0.86